Skip to content

13F-HR filed by CVI Holdings, LLC

CVI Holdings, LLC filed this 13F-HR for the quarter ended 2018-06-30, filed 2018-08-14, with 53 holding rows worth $80,338,000.

Accession
0001728194-18-000011
Filed
2018-08-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2018

A holdings report, 53 entries on the cover page, a total value of $80,338,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $80,338,000 with VALUE read as thousands by filing date, 13F file number 028-18767. The quarter's positions are built on this report. The resolved quarter.

Other managers

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
TIMKENSTEEL CORP887399AA1CONVERTIBLE BOND10,455,000$16,088,000thousands by filing dateprincipal
EROS INTL PLCG3788M114SHS NEW960,238$12,483,000thousands by filing date
ANI PHARMACEUTICALS INC00182CAA1NOTE 3.00012/09,000,000$10,149,000thousands by filing dateprincipal
NOVAVAX INC670002104COMMON STOCK3,315,597$4,443,000thousands by filing date
VERITONE INC92347M100COM261,422$4,397,000thousands by filing date
VASCULAR BIOGENICS LTDM96883109COM1,896,902$4,173,000thousands by filing date
TELLURIAN INC NEW87968A104COM454,294$3,780,000thousands by filing date
CATABASIS PHARMACEUTICALS IN14875P107COM2,680,752$2,571,000thousands by filing date
HELIOS & MATHESON ANALYTICS42327L200COM NEW8,023,500$2,487,000thousands by filing date
TapImmune Inc876033408COM250,000$2,358,000thousands by filing date
SENSEONICS HLDGS INC81727UAA3NOTE 5.250% 2/01,500,000$2,130,000thousands by filing dateprincipal
AERPIO PHARMACEUTICALS INC00810B105COM450,676$1,870,000thousands by filing date
Egalet Corporation28226BAB0Note 5.50% 4/1/204,500,000$1,572,000thousands by filing dateprincipal
KURA ONCOLOGY INC COM50127T109Stock76,200$1,387,000thousands by filing date
NOVAN INC66988N106COM405,131$1,191,000thousands by filing date
AURYN RES INC05208W108COM978,630$1,067,000thousands by filing date
ARCADIA BIOSCIENCES INC COM039014204Stock119,333$984,000thousands by filing date
PROFIRE ENERGY INC74316X101COM277,721$939,000thousands by filing date
CEL-SCI CORP150837607COM PAR NEW801,006$737,000thousands by filing date
CHF SOLUTIONS INC12542Q508COM NEW347,895$640,000thousands by filing date
LIMONEIRA CO532746104COM25,946$639,000thousands by filing date
APPLIED DNA SCIENCES INC03815U201COM NEW494,463$623,000thousands by filing date
RECON TECHNOLOGY LTDG7415M108SHS354,572$493,000thousands by filing date
KINDRED BIOSCIENCES INC COM494577109Stock45,057$480,000thousands by filing date
SEACOR MARINE HLDGS INC COM78413P101Stock17,809$411,000thousands by filing date
SCYNEXIS INC COM NEW811292101Common Stock236,531$388,000thousands by filing date
FIBROCELL SCIENCE INC315721407COM117,099$317,000thousands by filing date
INVIVO THERAPEUTICS HLDGS CO COM46186M407Stock156,655$266,000thousands by filing date
TROVAGENE INC COM PAR897238408Stock307,445$237,000thousands by filing date
GALMED PHARMACEUTICALS LTDM47238106SHS14,895$177,000thousands by filing date
PLX PHARMA INC. XXXBANKRUPTCY EFF: 10/02/2372942A107COMMON STOCK29,282$116,000thousands by filing date
SEANERGY MARITIME HLDGS CORPY73760145*W EXP 11/10/2021,180,400$97,000thousands by filing date
CHECK CAP LTDM2361E161*W EXP 05/03/202136,364$93,000thousands by filing date
BIONDVAX PHARMACEUTICALS LTD09073Q113*W EXP 05/15/20272,800$92,000thousands by filing date
SIGMA LABS INC826598112*W EXP 02/15/202214,500$75,000thousands by filing date
QUICKLOGIC CORP74837P108COM58,043$67,000thousands by filing date
RXI PHARMACEUTICALS CORP NEW74979C121*W EXP 12/16/202221,056$55,000thousands by filing date
IMMUNE PHARMACEUTICALS INC45254C200COM NEW251,029$47,000thousands by filing date
IMMURON LTDQ4867H223*W EXP 06/08/20215,041$47,000thousands by filing date
CELLECTAR BIOSCIENCES INC15117F138*W EXP 04/20/202207,500$39,000thousands by filing date
RESHAPE LIFESCIENCES INC761123405COM NEW16,574$38,000thousands by filing date
CELLECT BIOTECHNOLOGY LTD15116C110*W EXP 08/03/20212,570$25,000thousands by filing date
AMERI HLDGS INC WT EXP 11082302362F112Stock125,503$21,000thousands by filing date
SOLIGENIX INC834223117*W EXP 11/14/20261,000$17,000thousands by filing date
APPLIED DNA SCIENCES INC03815U110*W EXP 11/21/20131,407$9,000thousands by filing date
CYTORI THERAPEUTICS INC23283K139*W EXP 05/28/202259,200$8,000thousands by filing date
BENITEC BIOPHARMA LTD082053117*W EXP 08/14/20250,000$6,000thousands by filing date
MYND ANALYTICS INC62857N111*W EXP 06/29/20213,700$3,000thousands by filing date
ONCONOVA THERAPEUTICS INC68232V116*W EXP 07/11/202173,112$2,000thousands by filing date
ADVAXIS INC007624117*W EXP 10/22/20115,150$2,000thousands by filing date
INSPIREMD INC45779A135*W EXP 03/14/20248,000$1,000thousands by filing date
EYEGATE PHARMACEUTICALS INC30233M115*W EXP 08/05/20212,900$1,000thousands by filing date
ENERGY FUELS INC292671179*W EXP 09/277,777$0thousands by filing dateValue filed as zero, left out of ratios.

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001728194-18-000011this filing2018-08-14acceptance time not in the bulk data set